홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1-[5-Chloro-4-(1-methylethyl)amino-3-pyridazinyl]piperazine → 1-[4-(1-Methylethyl)amino-3-pyridazinyl]piperazine

HRID 2293744
인쇄

반응식

HRID 2293744 반응식
Cl[C:2]1[C:3]([NH:14][CH:15]([CH3:17])[CH3:16])=[C:4]([N:8]2[CH2:13][CH2:12][NH:11][CH2:10][CH2:9]2)[N:5]=[N:6][CH:7]=1>C(N(CC)CC)C>[CH3:17][CH:15]([NH:14][C:3]1[CH:2]=[CH:7][N:6]=[N:5][C:4]=1[N:8]1[CH2:9][CH2:10][NH:11][CH2:12][CH2:13]1)[CH3:16]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 1

HCID 214776731-[5-Chloro-4-(1-methylethyl)amino-3-pyridazinyl]piperazine

생성물 1

HCID 214776131-[4-(1-Methylethyl)amino-3-pyridazinyl]piperazine

시약·촉매·용매 1

HCID 8471Triethylamine용매

실험 절차

Following the general procedure of PREPARATION 10 and making non-critical variations but starting with 1-[5-chloro-4-(1-methylethyl)amino-3-pyridazinyl]piperazine (PREPARATION 42, 1.7 g) and triethylamine (0.81 g), the title compound is obtained, NMR (CDCl3) 1.28, 2.06, 3.05, 3.11, 3.59, 4.75, 6.39, and 8.49 δ; CMR (CDCl3) 22.2, 43.2, 46.2, 50.6, 103.7, 138.7, 148.4 and 154.5 δ.

후처리

  1. customthe general procedure of PREPARATION 10

출처 및 근거

ORD 기록
ord-b4fff19ccddf4abd9dc13f2ebea2e896
출처 데이터셋
uspto-grants-1997_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US05686610

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트